Treprostinil 1 mg/ml solution for infusion
Solution for infusion
Compare
|
PA23092/002/001
Authorised: 26/08/2022
Reddy Holding GmbH
|
SPC
PIL
|
Treprostinil 10 mg/ml solution for infusion
Solution for infusion
Compare
|
PA23092/002/004
Authorised: 26/08/2022
Reddy Holding GmbH
|
SPC
PIL
|
Treprostinil 2.5 mg/ml solution for infusion
Solution for infusion
Compare
|
PA23092/002/002
Authorised: 26/08/2022
Reddy Holding GmbH
|
SPC
PIL
|
Treprostinil 5 mg/ml solution for infusion
Solution for infusion
Compare
|
PA23092/002/003
Authorised: 26/08/2022
Reddy Holding GmbH
|
SPC
PIL
|
Treprostinil Tillomed 1 mg/ml solution for infusion
Solution for infusion
Compare
|
PA22720/011/001
Authorised: 30/09/2022
Tillomed Pharma GmbH
|
SPC
PIL
EdM
|
Treprostinil Tillomed 10 mg/ml solution for infusion
Solution for infusion
Compare
|
PA22720/011/004
Authorised: 30/09/2022
Tillomed Pharma GmbH
|
SPC
PIL
EdM
|
Treprostinil Tillomed 2.5 mg/ml solution for infusion
Solution for infusion
Compare
|
PA22720/011/002
Authorised: 30/09/2022
Tillomed Pharma GmbH
|
SPC
PIL
EdM
|
Treprostinil Tillomed 5 mg/ml solution for infusion
Solution for infusion
Compare
|
PA22720/011/003
Authorised: 30/09/2022
Tillomed Pharma GmbH
|
SPC
PIL
EdM
|
Trepulmix
Solution for infusion
Compare
|
EU/1/19/1419/001
Authorised: 03/04/2020
Scipharm S.à.r.l.
|
SPC
PIL
IPAR
|
Trepulmix
Solution for infusion
Compare
|
EU/1/19/1419/002
Authorised: 03/04/2020
Scipharm S.à.r.l.
|
SPC
PIL
IPAR
|
Trepulmix
Solution for infusion
Compare
|
EU/1/19/1419/003
Authorised: 03/04/2020
Scipharm S.à.r.l.
|
SPC
PIL
IPAR
|
Trepulmix
Solution for infusion
Compare
|
EU/1/19/1419/004
Authorised: 03/04/2020
Scipharm S.à.r.l.
|
SPC
PIL
IPAR
|
Tresiba
Solution for injection
Compare
|
EU/1/12/807/1,4,5,7,8
Authorised: 21/01/2013
Novo Nordisk A/S
|
SPC
PIL
IPAR
EdM
|
Tresiba
Solution for injection in pre-filled pen
Compare
|
EU/1/12/807/9,12,13,15
Novo Nordisk A/S
|
SPC
PIL
IPAR
EdM
|
TREVACLYN 1000 MG/20 MG MODIFIED-RELEASE TABLETS.
Modified-release tablet
Compare
|
EU/1/08/458/1-11
Authorised: 03/07/2008
Merck Sharp and Dohme Limited
|
SPC
PIL
IPAR
|
TREVICTA
Prolonged-release suspension for injection
Compare
|
EU/1/14/971/007
Authorised: 26/05/2016
Janssen-Cilag International NV
|
SPC
PIL
IPAR
|
TREVICTA
Prolonged-release suspension for injection
Compare
|
EU/1/14/971/008
Authorised: 26/05/2016
Janssen-Cilag International NV
|
SPC
PIL
IPAR
|
TREVICTA
Prolonged-release suspension for injection
Compare
|
EU/1/14/971/009
Authorised: 26/05/2016
Janssen-Cilag International NV
|
SPC
PIL
IPAR
|
TREVICTA
Prolonged-release suspension for injection
Compare
|
EU/1/14/971/010
Authorised: 26/05/2016
Janssen-Cilag International NV
|
SPC
PIL
IPAR
|
Triapin 2.5mg/2.5mg prolonged release tablet
Prolonged-release tablet
Compare
|
PA0540/082/001
Authorised: 13/07/1998
Sanofi-Aventis Ireland Limited T/A SANOFI
|
SPC
PIL
|